Climb Bio Q3 EPS $(0.18) Beats $(0.20) Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 5.26 percent increase over losses of $(0.19) per share from the same
Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 5.26 percent increase over losses of $(0.19) per share from the same period last year.